Figure 4From: Effect of lisdexamfetamine dimesylate on sleep in adults with attention-deficit/hyperactivity disorderPSQI global scores for subjects reporting sleep-related TEAEs. PSQI scores are not worse at 4 weeks for subjects who reported sleep-related TEAEs. Numbers within bars indicate numbers of subjects. (TEAEs = treatment-emergent adverse events; PSQI = Pittsburgh Sleep Quality Index; LDX = lisdexamfetamine dimesylate; SD = standard deviation).Back to article page